Table 4.

Cause specific survival for 1,009 endometrial cancer patients related to clinicopathologic variables and Stathmin expression

VariablenNumber of deaths% 5-year survivalP
Age, y<0.001
 <664992892
 ≥665107775
Menopause status0.003
 Pre/perimenopausal105396
 Postmenopausal90410283
FIGO<0.001
 I, II8313793
 III, IV1786842
Histologic type<0.001
 Endometrioid8254491
 Nonendometrioid1846151
Histologic gradea <0.001
 Grade 1, 26862893
 Grade 33177765
Ploidyb <0.001
 Diploid2942489
 Aneuploid761969
Lymph node metastasisc <0.001
 Negative6192892
 Positive892849
Stathmin curettaged <0.001
 Weak expression4873788
 Strong expression2914377
Stathmin hysterectomye 0.002
 Weak expression3934488
 Strong expression842069

NOTE: Of 1,076 patients, 67 not yet attended follow-up.

  • aMissing cases 6.

  • bPloidy data available for 370 patients.

  • cLymph node sampling conducted in 708 cases.

  • dStathmin curettage available for 778 patients.

  • eStathmin hysterectomy available in 477 cases.